Showing results (161-170 of 297) with videos related to
Sort By:
Pageof 30
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2017
The Impact of Couple HIV Testing and Counseling on Consistent Condom Use Among Pregnant Women and Their Male Partners: An Observational StudyNora E Rosenberg, Lauren A Graybill, Austin Wesevich, et al.Investigational New Drugs|December 18, 2009
Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trialSimon Pacey, Mark J Ratain, Keith T Flaherty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokineticsFederico Innocenti, Deanna L Kroetz, Erin Schuetz, et al.Clinical and Translational Science|April 8, 2026
Evaluating Perceived Value of Pharmacogenomic Testing After a Personalized Therapeutics Clinic ConsultationThomas Chen, Amanda S Andriessen, Matthew Jack, et al.Cancer Chemotherapy and Pharmacology|September 15, 2005
Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B studyCheri E Klein, Helen Kastrissios, Antonius A Miller, et al.Nature Reviews. Drug Discovery|July 1, 2008
Creating and evaluating genetic tests predictive of drug responseScott T Weiss, Howard L McLeod, David A Flockhart, et al.The Lancet. Oncology|October 3, 2024
The tyranny of non-inferiority trialsIan F Tannock, Marc Buyse, Mickael De Backer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Phase I study of an oral formulation of ZD9331 administered daily for 28 daysMichael B Sawyer, Mark J Ratain, Donna Bertucci, et al.Pharmacogenetics and Genomics|July 16, 2008
Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 geneFederico Innocenti, Wanqing Liu, Donna Fackenthal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignanciesTodd M Zimmerman, Helena Harlin, Olatoyosi M Odenike, et al.Pageof 30